Zomedica to Participate in the Lytham Partners 2024 Investor Select Conference

ANN ARBOR, MI / ACCESSWIRE / January 30, 2024 / Zomedica Corp. (NYSE American:ZOM) (“Zomedica” or the “Company”), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion anima…

ANN ARBOR, MI / ACCESSWIRE / January 30, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced that Larry Heaton, Chief Executive Officer, will participate in a fireside chat and host one-on-one meetings with investors at the Lytham Partners 2024 Investor Select Conference, taking place virtually on February 1st, 2024.

The Company’s webcasted fireside chat will take place at 10:15am ET on Thursday, February 1, 2024. The webcast can be accessed on the Company’s website at https://investors.zomedica.com/ or directly at https://wsw.com/webcast/lytham10/zom/1948896. The webcast will also be archived and available for replay.

About Zomedica
Based in Ann Arbor, Michigan, Zomedica (NYSE American:ZOM) is a veterinary health company creating products for horses, dogs, and cats by focusing on the unmet needs of clinical veterinarians. Zomedica’s product portfolio includes innovative diagnostics and medical devices that emphasize patient health and practice health. Zomedica’s mission is to provide veterinarians the opportunity to increase productivity and grow revenue while better serving the animals in their care. For more information, visit https://www.zomedica.com.

Follow Zomedica
Email Alerts: http://investors.zomedica.com

LinkedIn: https://www.linkedin.com/company/zomedica

Facebook: https://m.facebook.com/zomedica

Twitter: https://twitter.com/zomedica

Instagram: https://www.instagram.com/zomedica_inc

Investor Relations Contact:
Zomedica Investor Relations
investors@zomedica.com
1-734-369-2555

Investor Contacts
Lytham Partners, LLC
Robert Blum
1-602-889-9700

SOURCE: Zomedica Corp.

View the original press release on accesswire.com

Previous Article

Essex Realty Group, Inc. Announces Launch of New Entity: Essex Capital Markets

Next Article

Being Proactive in Retirement: Westchester County Elder Law Attorney Anthony J. Enea Emphasizes the Importance of Advanced Planning

Related Posts

MNK INVESTOR NEWS: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Mallinckrodt plc Investors to Inquire About Securities Class Action Investigation – MNK

NEW YORK, April 14, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues investigating potential securities claims on behalf of shareholders of Mallinckrodt plc (NYSE American: MNK) resulting from allegations that Mallinckrodt may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Mallinckrodt […]